Showing 1 - 20 results of 489 for search '"Аортокоронарное шунтирование"', query time: 0.90s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal

    Contributors: Авторы заявляют об отсутствии финансирования исследования.

    Source: Complex Issues of Cardiovascular Diseases; Том 14, № 5 (2025); 27-35 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 5 (2025); 27-35 ; 2587-9537 ; 2306-1278

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1601/1084; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1601/1908; Moreno-Angarita, A., Peña, D., de León, J.D.LP. et al. Current indications and surgical strategies for myocardial revascularization in patients with left ventricular dysfunction: a scoping review. J Cardiothorac Surg 19, 469 (2024). https://doi.org/10.1186/s13019-024-02844-2; Алекян Б.Г., Бойцов С.А., Маношкина Е.М., Ганюков В.И. Реваскуляризация миокарда в Российской Федерации при остром коронарном синдроме в 2016-2020 гг. Кардиология. 2021;61(12):4-15. https://doi.org/10.18087/cardio.2021.12.n1879; Иванов С.В., Сумин А.Н. Современные тенденции рутинной реваскуляризации миокарда. Комплексные проблемы сердечно-сосудистых заболеваний. 2021;10(2):25-35. https://doi.org/10.17802/2306-1278-2021-10-2-25-35; Llerena-Velastegui J, Zumbana-Podaneva K, Velastegui-Zurita S, Mejia-Mora M, Perez-Tomassetti J, Cabrera-Cruz A, Haro-Arteaga P, de Jesus ACFS, Coelho PM, Sanahuja-Montiel C. Comparative Efficacy of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in the Treatment of Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials. Cardiol Res. 2024 Jun;15(3):153-168. doi:10.14740/cr1638.; Барбараш О.Л., Карпов Ю.А., Панов А.В., и др. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):6110. doi:10.15829/1560-4071-2024-6110.; Российское кардиологическое общество (РКО) . Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации; Cui K, Liu H, Yuan F, et al. Coronary artery bypass graft surgery versus stenting for patients with chronic kidney disease and complex coronary artery disease: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease. 2021;12. doi:10.1177/2040622321990273; Caldonazo, T., Kirov, H., Riedel, L.L. et al. Comparing CABG and PCI across the globe based on current regional registry evidence. Sci Rep 12, 22164 (2022). https://doi.org/10.1038/s41598-022-25853-4; Самородская И.В. , Какорина Е.П. Динамика хирургического и эндоваскулярного лечения ишемической болезни сердца в Российской Федерации (2014-2023гг). Часть 1. Комплексные проблемы сердечно-сосудистых заболеваний. 2025 (принята к печати); Барбараш О.Л., Кашталап В.В., Шибанова И.А., Коков А.Н. Фундаментальные и прикладные аспекты кальцификации коронарных артерий. Российский кардиологический журнал. 2020;25(3S):4005. https://doi.org/10.15829/1560-4071-2020-4005; Nogueira-Garcia B, Vilela M, Oliveira C, Caldeira D, Martins AM, Nobre Menezes M. A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions. J Pers Med. 2024 May 10;14(5):506. doi:10.3390/jpm14050506.; Patel KK, Peri-Okonny PA, Giorgetti A, Shaw LJ, Gimelli A. Value of Ischemia and Coronary Anatomy in Prognosis and Guiding Revascularization Among Patients With Stable Ischemic Heart Disease. Circ Cardiovasc Imaging. 2024 Sep;17(9):e016587. doi:10.1161/CIRCIMAGING.123.016587.; Bangalore S, Rhodes G, Maron DJ, Anthopolos R, O'Brien SM, Jones PG, Mark DB, Reynolds HR, Spertus JA, Stone GW, White HD, Xu Y, Fremes SE, Hochman JS, Ischemia Research Group OBOT. Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial. EuroIntervention. 2024 Oct 21;20(20):e1276-e1287. doi:10.4244/EIJ-D-24-00240.; Timmis A, Aboyans V, Vardas P, Townsend N, Torbica A, Kavousi M, Boriani G, Huculeci R, Kazakiewicz D, Scherr D, Karagiannidis E, Cvijic M, Kapłon-Cieślicka A, Ignatiuk B, Raatikainen P, De Smedt D, Wood A, Dudek D, Van Belle E, Weidinger F; ESC National Cardiac Societies. European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics. Eur Heart J. 2024 Oct 7;45(38):4019-4062. doi:10.1093/eurheartj/ehae466.; Kumsa NB, Kelly TL, Roughead EE, Tavella R, Gillam MH. Temporal trends in percutaneous coronary intervention in Australia: A retrospective analysis from 2000-2021. Hellenic J Cardiol. 2024 Nov-Dec;80:21-30. doi:10.1016/j.hjc.2023.10.002; Tam DY, Qiu F, Manoragavan R, Fremes SE, Hassan A, Ko DT, Lauck SB, Naimark D, Ouzounian M, Sander B, Sun L, Wijeysundera HC. The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada. Can J Cardiol. 2021 Oct;37(10):1547-1554. doi:10.1016/j.cjca.2021.05.008.; Aranda-Michel E, Serna-Gallegos D, Arnaoutakis G, Kilic A, Brown JA, Dai Y, Dunn-Lewis C, Sultan I. The Effect of COVID-19 on Cardiac Surgical Volume and its Associated Costs. Semin Thorac Cardiovasc Surg. 2023 Autumn;35(3):508-515. doi:10.1053/j.semtcvs.2022.01.009.; Ivert T, Dalén M, Friberg Ö. Effect of COVID-19 on cardiac surgery volumes in Sweden. Scand Cardiovasc J. 2023 Dec;57(1):2166102. doi:10.1080/14017431.2023.2166102.; Goicolea Ruigómez FJ, Elola FJ, Durante-López A, Fernández Pérez C, Bernal JL, Macaya C. Coronary artery bypass grafting in Spain. Influence of procedural volume on outcomes. Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):488-494. English, Spanish. doi:10.1016/j.rec.2019.08.016; Jones DA, Gallagher S, Rathod K, Jain AK, Mathur A, Uppal R, Westwood M, Wong K, Rothman MT, Shipolini A, Smith EJ, Mills PG, Timmis AD, Knight CJ, Archbold RA, Wragg A. Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. Eur Heart J. 2013 Oct;34(37):2887-95. doi:10.1093/eurheartj/eht161.; Эфрос Л.А., Лукин О.П., Самородская И.В., Семенов В.Ю., Сумин А.Н., Иванов С.В., Евсеева М.В., Барбараш О.Л. Коморбидная патология у больных ишемической болезнью сердца при коронарном шунтировании среди пациентов кардиохирургических центров Челябинска и Кемерово. Комплексные проблемы сердечно-сосудистых заболеваний. 2017;6(4):71-79. https://doi.org/10.17802/2306-1278-2017-6-4-71-79 (In Russ.); Барбараш О.Л., Семенов В.Ю., Самородская И.В., Евсеева М.В., Рожков Н.А., Сумин А.Н., Барбараш Л.С. Коморбидная патология у больных ишемической болезнью сердца при коронарном шунтировании: опыт двух кардиохирургических центров. Российский кардиологический журнал. 2017;(3):6-13. https://doi.org/10.15829/1560-4071-2017-3-6-13

  8. 8
    Academic Journal

    Contributors: The study was supported by the grant from the Russian Science Foundation No. 23-75-00009, https://rscf.ru/project/23-75-00009/, Исследование выполнено за счет гранта Российского научного фонда № 23-75-00009, https://rscf.ru/project/23-75-00009/

    Source: Complex Issues of Cardiovascular Diseases; Том 14, № 4 (2025); 18-27 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 4 (2025); 18-27 ; 2587-9537 ; 2306-1278

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1670/1069; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1670/2067; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1670/2068; Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023 Jan 18;118(17):3272-3287. doi:10.1093/cvr/cvac013. Erratum in: Cardiovasc Res. 2023 Jun 13;119(6):1453. doi:10.1093/cvr/cvad026.; Шляхто Е.В., Беленков Ю.Н., Бойцов С.А., Виллевальде С.В., Галявич А.С., Глезер М.Г., и др. Результаты промежуточного анализа проспективного наблюдательного многоцентрового регистрового исследования пациентов с хронической сердечной недостаточностью в Российской Федерации "ПРИОРИТЕТ-ХСН": исходные характеристики и лечение первых включенных пациентов. Российский кардиологический журнал. 2023;28(10):5593. doi:10.15829/1560-4071-2023-5593.; Canepa M, Anastasia G, Ameri P, Vergallo R, O'Connor CM, Sinagra G, Porto I. Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis. Eur J Intern Med. 2025 Feb 11:S0953-6205(25)00042-1. doi:10.1016/j.ejim.2025.02.004. Epub ahead of print. PMID: 39939263.; Panza JA, Ellis AM, Al-Khalidi HR, et al. Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. N Engl J Med. 2019 Aug 22;381(8):739-748. doi:10.1056/NEJMoa1807365; Heusch G. Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease. Med. 2024 Jan 12;5(1):10-31. doi:10.1016/j.medj.2023.12.007. PMID: 38218174.; Khoynezhad A, Jalali Z, Tortolani AJ. Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon. Ann Thorac Surg. 2004 Sep;78(3):1109-18. doi:10.1016/j.athoracsur.2003.06.034. PMID: 15337071.; Cocchi MN, Salciccioli J, Yankama T, Chase M, Patel PV, Liu X, et al. Predicting Outcome After Out-of-Hospital Cardiac Arrest: Lactate, Need for Vasopressors, and Cytochrome c. J Intensive Care Med. 2020 Dec;35(12):1483-1489. doi:10.1177/0885066619873315. Epub 2019 Aug 29. PMID: 31466497.; Andersen LW, Liu X, Montissol S, Holmberg MJ, Fabian-Jessing BK, Donnino MW; Center for Resuscitation Science Research Group. Cytochrome c in patients undergoing coronary artery bypass grafting: A post hoc analysis of a randomized trial. J Crit Care. 2017 Dec;42:248-254. doi:10.1016/j.jcrc.2017.08.006.; Гарганеева А.А., Кужелева Е.А., Тукиш О.В., Витт К.Н., Андреев С.Л., Муслимова Э.Ф., Корепанов В.А., Афанасьев С.А., Гуля М.О., Сыромятникова Е.Е., Владимирова Е.А., Степанов И.В. Возможности диагностики митохондриальной дисфункции при хронической сердечной недостаточности. Сибирский журнал клинической и экспериментальной медицины. 2024;39(3):51–57. https://doi.org/10.29001/2073-8552-2024-39-3-51-57; Alves-Figueiredo H, Silva-Platas C, Lozano O, Vázquez-Garza E, Guerrero-Beltrán CE, Zarain-Herzberg A, García-Rivas G. « A systematic review of post-translational modifications in the mitochondrial permeability transition pore complex associated with cardiac diseases. Biochim Biophys Acta Mol Basis Dis. 2021 Jan 1;1867(1):165992. doi:10.1016/j.bbadis.2020.165992; Paraskevaidis I, Kourek C, Farmakis D, Tsougos E., «Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell. Biomolecules. 2024 Nov 29;14(12):1534. doi:10.3390/biom14121534. PMID: 39766241; PMCID: PMC11673776.; Галявич А. С., Терещенко С. Н., Ускач Т. М., Агеев Ф. Т., Аронов Д. М., Арутюнов Г. П., и др. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11):6162. doi:10.15829/1560-4071-2024-6162.; Goedeke L, Ma Y, Gaspar RC, Nasiri A, Lee J, Zhang D, Galsgaard KD, Hu X, Zhang J, Guerrera N, Li X, LaMoia T, Hubbard BT, Haedersdal S, Wu X, Stack J, Dufour S, Butrico GM, Kahn M, Perry RJ, Cline GW, Young LH, Shulman GI. SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts. J Clin Invest. 2024 Dec 16;134(24):e176708. doi:10.1172/JCI176708.; Shu H, Hang W, Peng Y, Nie J, Wu L, Zhang W, Wang DW, Zhou N. Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK. Front Pharmacol. 2021 Sep 15;12:707399. doi:10.3389/fphar.2021.707399. PMID: 34603021; PMCID: PMC8479198.; Shah YR, Turgeon RD. Impact of SGLT2 Inhibitors on Quality of Life in Heart Failure Across the Ejection Fraction Spectrum: Systematic Review and Meta-analysis. CJC Open. 2023 Dec 10;6(4):639-648. doi:10.1016/j.cjco.2023.12.002.; Nassiri S, Van de Bovenkamp AA, Remmelzwaal S, Sorea O, de Man F, Handoko ML. Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis. Open Heart. 2024 May 8;11(1):e002579. doi:10.1136/openhrt-2023-002579. PMID: 38719498; PMCID: PMC11086535.

  9. 9
    Academic Journal

    Contributors: Авторы заявляют об отсутствии финансирования исследования.

    Source: Complex Issues of Cardiovascular Diseases; Том 14, № 4 (2025); 68-76 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 4 (2025); 68-76 ; 2587-9537 ; 2306-1278

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1581/1078; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1581/1864; Барбараш О.Л., Карпов Ю.А., Панов А.В., и др. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):6110. doi:10.15829/1560-4071-2024-6110.; Российское кардиологическое общество (РКО). Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2020 // Российский кардиологический журнал. 2020 Т.25, №11. С.4103. doi:10.15829/29/1560-4071-2020-4103; Llerena-Velastegui J, Zumbana-Podaneva K, Velastegui-Zurita S, Mejia-Mora M, Perez-Tomassetti J, Cabrera-Cruz A, Haro-Arteaga P, de Jesus ACFS, Coelho PM, Sanahuja-Montiel C. Comparative Efficacy of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in the Treatment of Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials. Cardiol Res. 2024 Jun;15(3):153-168. doi:10.14740/cr1638.; Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e4-e17. doi:10.1161/CIR.0000000000001039.; Jobs A, Desch S, Freund A, Feistritzer HJ, Thiele H. Revascularization Strategy in Myocardial Infarction with Multivessel Disease. J Clin Med. 2024 Mar 26;13(7):1918. doi:10.3390/jcm13071918.; Timmis A, Aboyans V, Vardas P, Townsend N, Torbica A, Kavousi M, Boriani G, Huculeci R, Kazakiewicz D, Scherr D, Karagiannidis E, Cvijic M, Kapłon-Cieślicka A, Ignatiuk B, Raatikainen P, De Smedt D, Wood A, Dudek D, Van Belle E, Weidinger F; ESC National Cardiac Societies. European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics. Eur Heart J. 2024 Oct 7;45(38):4019-4062. doi:10.1093/eurheartj/ehae466.; https://data-explorer.oecd.org/; Shawon MSR, Falster MO, Hsu B, Yu J, Ooi SY, Jorm L. Trends and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in New South Wales from 2008 to 2019. Am J Cardiol. 2023 Jan 15;187:110-118. doi:10.1016/j.amjcard.2022.10.047; Alkhouli M, Alqahtani F, Kalra A, Gafoor S, Alhajji M, Alreshidan M, Holmes DR, Lerman A. Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016. JAMA Netw Open. 2020 Feb 5;3(2):e1921326. doi:10.1001/jamanetworkopen.2019.21326.; Семенов В.Ю., Коваленко О.А. Динамика операций коронарного шунтирования в некоторых федеральных округах Российской Федерации в 2019–2021 годах. Комплексные проблемы сердечно-сосудистых заболеваний. 2024;13(3): 83-91. DOI:10.17802/2306-1278-2024-13-3-83-91; Алекян Б.Г., Бойцов С.А., Маношкина Е.М., Ганюков В.И. Реваскуляризация миокарда в Российской Федерации при остром коронарном синдроме в 2016-2020 гг. Кардиология. 2021;61(12):4-15. https://doi.org/10.18087/cardio.2021.12.n1879; Алекян Б.Г., Бойцов С.А., Ганюков В.И., Маношкина Е.М. Влияние пандемии COVID-19 на реваскуляризацию миокарда у пациентов с острым коронарным синдромом в Российской Федерации. Рациональная Фармакотерапия в Кардиологии. 2022;18(4):411-419. https://doi.org/10.20996/1819-6446-2022-08-03; Klein LW, Abugroun A, Daoud H. Rates of revascularization and PCI:CABG ratio: a new indicator predicting in-hospital mortality in acute coronary syndromes. Coron Artery Dis. 2022 Mar 1;33(2):69-74. doi:10.1097/MCA.0000000000001073; Chua TKT, Gao F, Chia SY, Sin KYK, Naik MJ, Tan TE, Tham YC. Long-term mortality after isolated coronary artery bypass grafting and risk factors for mortality. J Cardiothorac Surg. 2024 Jul 10;19(1):429. doi:10.1186/s13019-024-02943-0.; Hokkanen, M., Huhtala, H., Laurikka, J. et al. The effect of postoperative complications on health-related quality of life and survival 12 years after coronary artery bypass grafting – a prospective cohort study. J Cardiothorac Surg 16, 173 (2021). https://doi.org/10.1186/s13019-021-01527-6; Almramhi, K., Aljehani, M., Bamuflih, M., Alghamdi, S. ., Banser, S. ., Almousa, A. ., ALABDULWAHAB, S. ., & Al-Ebrahim, K. . (2022). Frequency and Risk Factors of Unplanned 30-Day Readmission After Open Heart Surgeries: A Retrospective Study in a Tertiary Care Center. The Heart Surgery Forum, 25(4), E608-E615. https://doi.org/10.1532/hsf.4875; Silverborn, M., Heitmann, L.A., Sveinsdottir, N. et al. Non-infectious sternal dehiscence after coronary artery bypass surgery. J Cardiothorac Surg 17, 249 (2022). https://doi.org/10.1186/s13019-022-02015-1; Madhavan MV, Kirtane AJ, Redfors B, Généreux P, Ben-Yehuda O, Palmerini T, Benedetto U, Biondi-Zoccai G, Smits PC, von Birgelen C, Mehran R, McAndrew T, Serruys PW, Leon MB, Pocock SJ, Stone GW. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2020 Feb 18;75(6):590-604. doi:10.1016/j.jacc.2019.11.058; Krittanawong, C., Khawaja, M., Virk, H.U.H. et al. Strategies for chronic coronary disease: A brief guide for clinicians. npj Cardiovasc Health 1, 6 (2024). https://doi.org/10.1038/s44325-024-00006-w; Иванов С.В., Сумин А.Н. Современные тенденции рутинной реваскуляризации миокарда. Комплексные проблемы сердечно-сосудистых заболеваний. 2021;10(2):25-35. https://doi.org/10.17802/2306-1278-2021-10-2-25-35

  10. 10
  11. 11
    Academic Journal

    Contributors: Авторы заявляют об отсутствии финансирования исследования.

    Source: Complex Issues of Cardiovascular Diseases; Том 14, № 2 (2025); 41-48 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 2 (2025); 41-48 ; 2587-9537 ; 2306-1278

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/1338/1020; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1338/1344; Conen D., Alonso-Coello P., Douketis J., Chan M.T.V., Kurz A., Sigamani A., Parlow J.L., Wang C.Y., et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. J Eur Heart J. 2020;41:645–51. doi:10.1093/eurheartj/ehz431.; Dave S., Nirgude A., Gujjar P., Sharma R. Incidence and risk factors for development of atrial fibrillation after cardiac surgery under cardiopulmonary bypass. Indian J Anaesth. 2018;62:887–91. doi:10.4103/ija.IJA_6_18.; Omer S., Cornwell L.D., Bakshi A., Rachlin E., Preventza O., Rosengart T.K., Coselli J.S., LeMaire S.A., Petersen N.J., Pattakos G., Bakaeen F.G. Incidence, predictors, and impact of postoperative atrial fibrillation after coronary artery bypass grafting in military veterans. Tex Heart Inst J. 2016;43:397–403. doi:10.14503/THIJ-15-5532.; Gumprecht J., Domek M., Lip G.Y.H., Shantsila A. Invited review: Hypertension and atrial fibrillation: Epidemiology, pathophysiology, and implications for management. J Hum Hypertens. 2019;33:824–36. doi:10.1038/s41371-019-0279-7.; Weymann A., Popoy A.F., Sabashinikav A., Ali-Hasan-Al-Saegh S., Ryazanov M., Tse G., Mirhosseini S.J., Liu T., et al. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: A systematic review and meta-analysis. Kardiol Pol. 2018;76:440–51. doi:10.5603/KP.a2017.0242.; Pierri M.D., Crescenzi G., Zingaro C., D'Alfonso A., Capestro F., Scocco V., Brugia M., Torracca L. Prevention of atrial fibrillation and inflammatory response after on-pump coronary artery bypass using different statin dosages: A randomized, controlled trial. Gen Thorac Cardiovasc Surg. 2016;64:395–402. doi:10.1007/s11748-016-0647-y.; Tsai Y.T., Lai C.H,. Loh S.H., Lin C.Y., Lin Y.C., Lee C.Y., Ke H.Y., Tsai C.S. Assessment of the risk factors and outcomes for postoperative atrial fibrillation patients undergoing isolated coronary artery bypass grafting. Acta Cardiol Sin. 2015;31:436–43. doi:10.6515/acs20150609a.; Kawczynski M.J., Gilbers M., Van De Walle S., Schalla S., Crijns H.J., Maessen J.G., Schotten U., Maesen B., Bidar E. Role of pre-operative transthoracic echocardiography in predicting post-operative atrial fibrillation after cardiac surgery: A systematic review of the literature and meta-analysis. EP Eur. 2021;23:1731–1743. doi:10.1093/europace/euab095.; Mandoli G.E., Pastore M.C., Benfari G., Bisleri G., Maccherini M., Lisi G., Cameli P., Lisi M., Dokollari A., Carrucola C., Vigna M., Montesi G., Valente S., Mondillo S., Cameli M. Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation. Int. J. Cardiol. 2020;41:ehaa946.0054. doi:10.1093/ehjci/ehaa946.0054.; Pessoa-Amorim G., Mancio J., Vouga L., Ribeiro J., Gama V., Bettencourt N., Fontes-Carvalho R. Impaired Left Atrial Strain as a Predictor of New-onset Atrial Fibrillation After Aortic Valve Replacement Independently of Left Atrial Size. Rev. Española Cardiol. 2017;71:466–476. doi:10.1016/j.recesp.2017.09.020.; Sabry A.M., Mansour H.A.E., Abo El-azm T.H., Mostafa S.A., Zahid B.S. Echocardiographic predictors of atrial fibrillation after mitral valve replacement. Egypt. Hear. J. 2017;69:281–288. doi:10.1016/j.ehj.2017.07.002.; Aksu U., Kalkan K., Gulcu O., Aksakal E., Öztürk M., Topcu S. The role of the right atrium in development of postoperative atrial fibrillation: A speckle tracking echocardiography study. J. Clin. Ultrasound. 2019;47:470–476. doi:10.1002/jcu.22736.; Ciuffo L., Tao S., Gucuk Ipek E., Zghaib T., Balouch M., Lima J.A.C., Nazarian S., Spragg D.D., Marine J.E., Berger R.D., Calkins H., Ashikaga H. Intra-Atrial Dyssynchrony During Sinus Rhythm Predicts Recurrence After the First Catheter Ablation for Atrial Fibrillation. JACC Cardiovasc. Imaging. 2019;12:310–319. doi:10.1016/j.jcmg.2017.11.028.; Osranek M., Fatema K., Qaddoura F., Al-Saileek A., Barnes M.E., Bailey K.R., Gersh B.J., Tsang T.S., Zehr K.J., Seward J.B. Left Atrial Volume Predicts the Risk of Atrial Fibrillation After Cardiac Surgery A Prospective Study. J. Am. Coll. Cardiol. 2006;48:779–786. doi:10.1016/j.jacc.2006.03.054.; Bessissow A., Khan J., Devereaux P.J., Alvarez-Garcia J., Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost. 2015;13 Suppl 1:S304-12. doi:10.1111/jth.12974.; Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., Lancellotti P., Muraru D., Picard M.H., Rietzschel E.R., Rudski L., Spencer K.T., Tsang W., Voigt J.U. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. doi:10.1016/j.echo.2014.10.003.; Pritchett A.M., Jacobsen S.J., Mahoney D.W., Rodeheffer R.J., Bailey K.R., Redfield M.M. Left atrial volume as an index of left atrial size: A population-based study. J Am Coll Cardiol. 2003;41:1036–43. doi:10.1016/s0735-1097(02)02981-9.; Brecher O., Gulati H., Roistacher N., Zhang H., Shi W., Thaler H.T., Amar D. Preoperative echocardiographic indices of diastolic dysfunction and brain natriuretic peptide in predicting postoperative atrial fibrillation after noncardiac surgery. Anesth Analg. (2017) 124:1099–104. doi:10.1213/ANE.0000000000001471.; Ai D,. Lasala J., Mehran J.R., Xu G., Banchs J., Cata J.P. Preoperative echocardiographic parameters of diastolic dysfunction did not provide a predictive value for postoperative atrial fibrillation in lung and esophageal cancer surgery. J Cardiothorac Vasc Anesth. (2015) 29:1127–30. doi:10.1053/j.jvca.2015.01.012; Mărgulescu A.D., Nuñez-Garcia M., Alarcón F., Benito E.M., Enomoto N., Cozzari J., Chipa F., Fernandez H., Borras R., Guasch E., Butakoff C., Tolosana J.M., Arbelo E., Camara O., Mont L. Reproducibility and accuracy of late gadolinium enhancement cardiac magnetic resonance measurements for the detection of left atrial fibrosis in patients undergoing atrial fibrillation ablation procedures. Europace.2019;21:724–731. doi:10.1093/europace/euy314.

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
    Academic Journal